Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Oct;62(10):4101–4106. doi: 10.1128/iai.62.10.4101-4106.1994

C9-mediated killing of bacterial cells by transferred C5b-8 complexes: transferred C5b-9 complexes are nonbactericidal.

K P Blanchard 1, J R Dankert 1
PMCID: PMC303082  PMID: 7927662

Abstract

The formation of the C5b-9 complex on the outer membrane of complement-sensitive cells of Escherichia coli results in inhibition of inner membrane function and the death of the cell. Cells bearing a precursor of the C5b-9 site, the C5b-8 complex, suffer no loss in viability. Antibiotic-sensitive, complement-sensitive donor cells bearing precursor C5b-8 complexes were incubated with equal numbers of antibiotic-resistant, complement-sensitive acceptor cells that had not been exposed to a complement source. This cell mixture was incubated with 5 mM EDTA for 5 min and then with calcium chloride (20 mM) for various times. The excess calcium ion concentration was effectively reduced with additional EDTA, and the cell mixture was washed and resuspended in buffer. The viability of the acceptor cells was assayed by plating on antibiotic-containing media. C9 was added to the mixture, and the mixture was incubated for 10 min at 37 degrees C and then plated as described above. It was found that the acceptor cells were killed by the addition of purified C9 only after incubation with donor cells bearing C5b-8 sites during the transfer procedure. This indicates that precursor C5b-8 sites that support C9-mediated killing could be transferred between cells. No loss in viability was detected for acceptor cells subjected to the procedure described above in the presence of donor cells bearing complete C5b-9 complexes, formed prior to mixing with acceptor cells for the transfer procedure.

Full text

PDF
4101

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bashford C. L., Alder G. M., Menestrina G., Micklem K. J., Murphy J. J., Pasternak C. A. Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents. A common mechanism blocked by divalent cations. J Biol Chem. 1986 Jul 15;261(20):9300–9308. [PubMed] [Google Scholar]
  2. Bayer M. E. Areas of adhesion between wall and membrane of Escherichia coli. J Gen Microbiol. 1968 Oct;53(3):395–404. doi: 10.1099/00221287-53-3-395. [DOI] [PubMed] [Google Scholar]
  3. Bayer M. E., Bayer M. H., Lunn C. A., Pigiet V. Association of thioredoxin with the inner membrane and adhesion sites in Escherichia coli. J Bacteriol. 1987 Jun;169(6):2659–2666. doi: 10.1128/jb.169.6.2659-2666.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bhakdi S., Ey P., Bhakdi-Lehnen B. Isolation of the terminal complement complex from target sheep erythrocyte membranes. Biochim Biophys Acta. 1976 Feb 6;419(3):445–457. doi: 10.1016/0005-2736(76)90258-3. [DOI] [PubMed] [Google Scholar]
  5. Bhakdi S., Kuller G., Muhly M., Fromm S., Seibert G., Parrisius J. Formation of transmural complement pores in serum-sensitive Escherichia coli. Infect Immun. 1987 Jan;55(1):206–210. doi: 10.1128/iai.55.1.206-210.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bhakdi S., Tranum-Jensen J. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore. J Immunol. 1986 Apr 15;136(8):2999–3005. [PubMed] [Google Scholar]
  7. Bhakdi S., Tranum-Jensen J. Re-incorporation of the terminal C5b-9 complement complex into lipid bilayers: formation and stability of reconstituted liposomes. Immunology. 1980 Nov;41(3):737–742. [PMC free article] [PubMed] [Google Scholar]
  8. Bloch E. F., Schmetz M. A., Foulds J., Hammer C. H., Frank M. M., Joiner K. A. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing. J Immunol. 1987 Feb 1;138(3):842–848. [PubMed] [Google Scholar]
  9. Braga L. L., Ninomiya H., McCoy J. J., Eacker S., Wiedmer T., Pham C., Wood S., Sims P. J., Petri W. A., Jr Inhibition of the complement membrane attack complex by the galactose-specific adhesion of Entamoeba histolytica. J Clin Invest. 1992 Sep;90(3):1131–1137. doi: 10.1172/JCI115931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brass J. M., Ehmann U., Bukau B. Reconstitution of maltose transport in Escherichia coli: conditions affecting import of maltose-binding protein into the periplasm of calcium-treated cells. J Bacteriol. 1983 Jul;155(1):97–106. doi: 10.1128/jb.155.1.97-106.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Brass J. M., Higgins C. F., Foley M., Rugman P. A., Birmingham J., Garland P. B. Lateral diffusion of proteins in the periplasm of Escherichia coli. J Bacteriol. 1986 Mar;165(3):787–795. doi: 10.1128/jb.165.3.787-795.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bukau B., Brass J. M., Boos W. Ca2+-induced permeabilization of the Escherichia coli outer membrane: comparison of transformation and reconstitution of binding-protein-dependent transport. J Bacteriol. 1985 Jul;163(1):61–68. doi: 10.1128/jb.163.1.61-68.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dankert J. R. Complement-mediated inhibition of function in complement-resistant Escherichia coli. J Immunol. 1989 Mar 1;142(5):1591–1595. [PubMed] [Google Scholar]
  14. Dankert J. R., Esser A. F. Bacterial killing by complement. C9-mediated killing in the absence of C5b-8. Biochem J. 1987 Jun 1;244(2):393–399. doi: 10.1042/bj2440393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dankert J. R., Esser A. F. Complement-mediated killing of Escherichia coli: dissipation of membrane potential by a C9-derived peptide. Biochemistry. 1986 Mar 11;25(5):1094–1100. doi: 10.1021/bi00353a023. [DOI] [PubMed] [Google Scholar]
  16. Dankert J. R. Resistance of Escherichia coli to osmotically introduced complement component C9. Infect Immun. 1991 Jan;59(1):109–113. doi: 10.1128/iai.59.1.109-113.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Griffiths E. Metabolically controlled killing of Pasteurella septica by antibody and complement. Biochim Biophys Acta. 1974 Oct 8;362(3):598–601. doi: 10.1016/0304-4165(74)90157-3. [DOI] [PubMed] [Google Scholar]
  18. Guihard G., Boulanger P., Bénédetti H., Lloubés R., Besnard M., Letellier L. Colicin A and the Tol proteins involved in its translocation are preferentially located in the contact sites between the inner and outer membranes of Escherichia coli cells. J Biol Chem. 1994 Feb 25;269(8):5874–5880. [PubMed] [Google Scholar]
  19. Hannavy K., Barr G. C., Dorman C. J., Adamson J., Mazengera L. R., Gallagher M. P., Evans J. S., Levine B. A., Trayer I. P., Higgins C. F. TonB protein of Salmonella typhimurium. A model for signal transduction between membranes. J Mol Biol. 1990 Dec 20;216(4):897–910. doi: 10.1016/S0022-2836(99)80009-6. [DOI] [PubMed] [Google Scholar]
  20. Harriman G. R., Podack E. R., Braude A. I., Corbeil L. C., Esser A. F., Curd J. G. Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death. J Exp Med. 1982 Oct 1;156(4):1235–1249. doi: 10.1084/jem.156.4.1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jaskula J. C., Letain T. E., Roof S. K., Skare J. T., Postle K. Role of the TonB amino terminus in energy transduction between membranes. J Bacteriol. 1994 Apr;176(8):2326–2338. doi: 10.1128/jb.176.8.2326-2338.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Joiner K. A., Schmetz M. A., Sanders M. E., Murray T. G., Hammer C. H., Dourmashkin R., Frank M. M. Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. Proc Natl Acad Sci U S A. 1985 Jul;82(14):4808–4812. doi: 10.1073/pnas.82.14.4808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Joseleau-Petit D., Kepes F., Peutat L., D'Ari R., Rothfield L. I. Biosynthesis of a membrane adhesion zone fraction throughout the cell cycle of Escherichia coli. J Bacteriol. 1990 Nov;172(11):6573–6575. doi: 10.1128/jb.172.11.6573-6575.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kroll H. P., Bhakdi S., Taylor P. W. Membrane changes induced by exposure of Escherichia coli to human serum. Infect Immun. 1983 Dec;42(3):1055–1066. doi: 10.1128/iai.42.3.1055-1066.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lachmann P. J. The control of homologous lysis. Immunol Today. 1991 Sep;12(9):312–315. doi: 10.1016/0167-5699(91)90005-E. [DOI] [PubMed] [Google Scholar]
  26. Lugtenberg B., Van Alphen L. Molecular architecture and functioning of the outer membrane of Escherichia coli and other gram-negative bacteria. Biochim Biophys Acta. 1983 Mar 21;737(1):51–115. doi: 10.1016/0304-4157(83)90014-x. [DOI] [PubMed] [Google Scholar]
  27. MacKay S. L., Dankert J. R. Affinity of the C9 molecule for the C5b-8 complex compared with that for the complex containing C9 molecules. Infect Immun. 1994 Jul;62(7):2800–2805. doi: 10.1128/iai.62.7.2800-2805.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. MacKay S. L., Dankert J. R. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites. J Immunol. 1990 Nov 15;145(10):3367–3371. [PubMed] [Google Scholar]
  29. Marvin H. J., ter Beest M. B., Hoekstra D., Witholt B. Fusion of small unilamellar vesicles with viable EDTA-treated Escherichia coli cells. J Bacteriol. 1989 Oct;171(10):5268–5275. doi: 10.1128/jb.171.10.5268-5275.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Morgan B. P., Meri S. Membrane proteins that protect against complement lysis. Springer Semin Immunopathol. 1994;15(4):369–396. doi: 10.1007/BF01837366. [DOI] [PubMed] [Google Scholar]
  31. Nakae T. Identification of the outer membrane protein of E. coli that produces transmembrane channels in reconstituted vesicle membranes. Biochem Biophys Res Commun. 1976 Aug 9;71(3):877–884. doi: 10.1016/0006-291x(76)90913-x. [DOI] [PubMed] [Google Scholar]
  32. Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother. 1989 Nov;33(11):1831–1836. doi: 10.1128/aac.33.11.1831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nikaido H., Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev. 1985 Mar;49(1):1–32. doi: 10.1128/mr.49.1.1-32.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Parsot C., Taxman E., Mekalanos J. J. ToxR regulates the production of lipoproteins and the expression of serum resistance in Vibrio cholerae. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1641–1645. doi: 10.1073/pnas.88.5.1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rice P. A. Molecular basis for serum resistance in Neisseria gonorrhoeae. Clin Microbiol Rev. 1989 Apr;2 (Suppl):S112–S117. doi: 10.1128/cmr.2.suppl.s112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Taylor P. W. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev. 1983 Mar;47(1):46–83. doi: 10.1128/mr.47.1.46-83.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Taylor P. W. Complement-mediated killing of susceptible gram-negative bacteria: an elusive mechanism. Exp Clin Immunogenet. 1992;9(1):48–56. [PubMed] [Google Scholar]
  38. Taylor P. W., Kroll H. P. Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli. Mol Immunol. 1984 Jul;21(7):609–620. doi: 10.1016/0161-5890(84)90046-4. [DOI] [PubMed] [Google Scholar]
  39. Taylor P. W., Kroll H. P. Killing of an encapsulated strain of Escherichia coli by human serum. Infect Immun. 1983 Jan;39(1):122–131. doi: 10.1128/iai.39.1.122-131.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tomlinson S., Taylor P. W., Luzio J. P. Transfer of phospholipid and protein into the envelope of gram-negative bacteria by liposome fusion. Biochemistry. 1989 Oct 17;28(21):8303–8311. doi: 10.1021/bi00447a007. [DOI] [PubMed] [Google Scholar]
  41. Tomlinson S., Taylor P. W., Luzio J. P. Transfer of preformed terminal C5b-9 complement complexes into the outer membrane of viable gram-negative bacteria: effect on viability and integrity. Biochemistry. 1990 Feb 20;29(7):1852–1860. doi: 10.1021/bi00459a027. [DOI] [PubMed] [Google Scholar]
  42. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev. 1992 Sep;56(3):395–411. doi: 10.1128/mr.56.3.395-411.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Verduin C. M., Jansze M., Hol C., Mollnes T. E., Verhoef J., van Dijk H. Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation. Infect Immun. 1994 Feb;62(2):589–595. doi: 10.1128/iai.62.2.589-595.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Vianney A., Lewin T. M., Beyer W. F., Jr, Lazzaroni J. C., Portalier R., Webster R. E. Membrane topology and mutational analysis of the TolQ protein of Escherichia coli required for the uptake of macromolecules and cell envelope integrity. J Bacteriol. 1994 Feb;176(3):822–829. doi: 10.1128/jb.176.3.822-829.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Walderich B., Höltje J. V. Specific localization of the lysis protein of bacteriophage MS2 in membrane adhesion sites of Escherichia coli. J Bacteriol. 1989 Jun;171(6):3331–3336. doi: 10.1128/jb.171.6.3331-3336.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES